Search

Search Constraints

You searched for: Author/Creator Engelman, Jeffrey A.

Search Results

1. Acquired Resistance to Crizotinib in NSCLC withMETExon 14 Skipping. Issue 8 (August 2016)

2. Acquired Resistance to First‐Line Afatinib and the Challenges of Prearranged Progression Biopsies. Issue 11 (November 2016)

3. Clinical Activity of Alectinib in AdvancedRET‐Rearranged Non–Small Cell Lung Cancer. Issue 11 (November 2016)

5. Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR‐Mutant Lung Cancer Harboring De NovoMETAmplification. Issue 7 (July 2016)

6. MET Exon 14 Skipping in Non-Small Cell Lung Cancer. (28th March 2016)

7. MET Exon 14 Skipping in Non‐Small Cell Lung Cancer. (28th March 2016)

10. Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment. Issue 11 (November 2016)